Phase III study of Hydrocortisone (Chronocort®) in patients with Congenital-adrenal-hyperplasia.
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2018
Price : $35 *
At a glance
- Drugs Hydrocortisone (Primary) ; Hydrocortisone
- Indications Adrenal insufficiency; Congenital adrenal hyperplasia
- Focus Registrational; Therapeutic Use
- Sponsors Diurnal
- 16 Mar 2018 New trial record
- 12 Mar 2018 According to the Diurnal media release, company plans to initiate this trial around the middle of 2018.